CLASS III Drug recall · Reported 10 Feb 2021 · FDA Enforcement Report

Oseltamivir Phosphate for Oral Suspension, 6 mg/mL recalled

Lupin Pharmaceuticals is recalling Oseltamivir Phosphate for Oral Suspension, 6 mg/mL (usable volume after constitution), distributed nationwide in the US. The recall was initiated on 21 Jan 2021 and the FDA has classified it as Class III.

Check your package

Lot, batch or date codesLot # A906423, exp. date Nov 2021.
NDC68180-678
Quantity recalled46,479 bottles

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0247-2021
FDA event ID
87195
Recalling firm
Lupin Pharmaceuticals, Baltimore, MD
Manufacturer
Lupin Pharmaceuticals, Inc.
Classification
Class III
Status
Terminated
Recall initiated
21 Jan 2021
FDA classified
3 Feb 2021
Reported
10 Feb 2021
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Potency & Assay

Timeline

21 Jan 2021Recall initiated by company
3 Feb 2021Classified by FDA+13 days
10 Feb 2021Published in enforcement report+7 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Failed Impurities/Degradation Specifications; Out-of-specification test results observed for Impurity C at 9 month long-term stability time point.

Potency and specification recalls happen when a batch tests outside its approved limits for strength, purity or dissolution, which can mean the dose delivered is higher or lower than labelled.

Product as listed by the FDA

Oseltamivir Phosphate for Oral Suspension, 6 mg/mL, 60 mL (usable volume after constitution), Rx only, Manufactured for:Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202, Manufactured by: Lupin Limited Aurangabad, Maharashtra, India. NDC: 68180-678-01

Where it was distributed

Nationwide

Nationwide

Questions about this recall

Why was it recalled?

Failed Impurities/Degradation Specifications; Out-of-specification test results observed for Impurity C at 9 month long-term stability time point.

Which lots are affected?

Lot # A906423, exp. date Nov 2021.

Where was it sold?

Nationwide

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class III mean?

Class III recalls are for products unlikely to cause any adverse health consequence, usually labelling or quality issues.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Lupin Pharmaceuticals

All 123
ReportedClassRecallCompanyReasonWhere
DrugCLASS IIClobetasol Propionate Cream USP, 0.05% tube recalledClobetasol PropionateLupin PharmaceuticalsOtherNationwide
DrugCLASS IIprednisoLONE Acetate Ophthalmic Suspension recalledPrednisolone AcetateLupin PharmaceuticalsOtherNationwide
DrugCLASS IIGlucagon Emergency Kit for Low Blood Sugar, Glucagon recalledGlucagonLupin PharmaceuticalsPotency & AssayNationwide
DrugCLASS IILiraglutide Injection, 18 mg/ (6 mg/mL) recalledLiraglutideLupin PharmaceuticalsParticulate MatterNationwide
DrugCLASS IISertraline Hydrochloride Tablets USP, 100 mg recalledSertraline HydrochlorideLupin PharmaceuticalsPackaging DefectsNationwide

Other Oseltamivir recalls

All 3
ReportedClassRecallCompanyReasonWhere
DrugCLASS IIOseltamivir Phosphate for Oral Suspension 6mg/ml (reconstituted) recalledOseltamivir PhosphateAmneal Pharmaceuticals of New YorkPotency & AssayNationwide
DrugCLASS IIOseltamivir Phosphate for Oral Suspension 6 mg/mL* *Each mL recalledOseltamivir Phosphate For Oral SuspensionCardinal HealthManufacturing (CGMP) DeviationsFL, GA, SC